Abstract: The chemokines CXCL9/Mig, CXCL10/IP-10, and CXCL11/I-TAC regulate lymphocyte chemotaxis, mediate vascular pericyte proliferation, and act as angiostatic agents, thus inhibiting tumor growth. These multiple activities are apparently mediated by a unique G protein-coupled receptor, termed CXCR3. The chemokine CXCL4/PF4 shares several activities with CXCL9, CXCL10, and CXCL11, including a powerful angiostatic effect, but its specific receptor is still unknown. Here, we describe a distinct, previously unrecognized receptor named CXCR3-B, derived from an alternative splicing of the CXCR3 gene that mediates the angiostatic activity of CXCR3 ligands and also acts as functional receptor for CXCL4. Human microvascular endothelial cell line-1 (HMEC-1), transfected with either the known CXCR3 (renamed CXCR3-A) or CXCR3-B, bound CXCL9, CXCL10, and CXCL11, whereas CXCL4 showed high affinity only for CXCR3-B. Overexpression of CXCR3-A induced an increase of survival, whereas overexpression of CXCR3-B dramatically reduced DNA synthesis and up-regulated apoptotic HMEC-1 death through activation of distinct signal transduction pathways. Remarkably, primary cultures of human microvascular endothelial cells, whose growth is inhibited by CXCL9, CXCL10, CXCL11, and CXCL4, expressed CXCR3-B, but not CXCR3-A. Finally, monoclonal antibodies raised to selectively recognize CXCR3-B reacted with endothelial cells from neoplastic tissues, providing evidence that CXCR3-B is also expressed in vivo and may account for the angiostatic effects of CXC chemokines. Evaluated by the FACULTY OF THOUSANDS. SCORE OF 4.8 MUST READ. PAPER CONTAINING A NEW FINDING AND A NOVEL INTERESTING HYPOTHESIS. IMPACT FACTOR 15.837

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 / L.Lasagni; M.Francalanci; F.Annunziato; E.Lazzeri; S.Giannini; L.Cosmi; C.Sagrinati; B.Mazzinghi; C.Orlando; E.Maggi; F.Marra; S.Romagnani; M.Serio; P.Romagnani. - In: JOURNAL OF EXPERIMENTAL MEDICINE. - ISSN 0022-1007. - STAMPA. - 197(2003), pp. 1537-1549. [10.1084/jem.20021897]

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.

LASAGNI, LAURA;ANNUNZIATO, FRANCESCO;LAZZERI, ELENA;COSMI, LORENZO;SAGRINATI, COSTANZA;MAZZINGHI, BENEDETTA;ORLANDO, CLAUDIO;MAGGI, ENRICO;MARRA, FABIO;ROMAGNANI, SERGIO;SERIO, MARIO;ROMAGNANI, PAOLA
2003

Abstract

Abstract: The chemokines CXCL9/Mig, CXCL10/IP-10, and CXCL11/I-TAC regulate lymphocyte chemotaxis, mediate vascular pericyte proliferation, and act as angiostatic agents, thus inhibiting tumor growth. These multiple activities are apparently mediated by a unique G protein-coupled receptor, termed CXCR3. The chemokine CXCL4/PF4 shares several activities with CXCL9, CXCL10, and CXCL11, including a powerful angiostatic effect, but its specific receptor is still unknown. Here, we describe a distinct, previously unrecognized receptor named CXCR3-B, derived from an alternative splicing of the CXCR3 gene that mediates the angiostatic activity of CXCR3 ligands and also acts as functional receptor for CXCL4. Human microvascular endothelial cell line-1 (HMEC-1), transfected with either the known CXCR3 (renamed CXCR3-A) or CXCR3-B, bound CXCL9, CXCL10, and CXCL11, whereas CXCL4 showed high affinity only for CXCR3-B. Overexpression of CXCR3-A induced an increase of survival, whereas overexpression of CXCR3-B dramatically reduced DNA synthesis and up-regulated apoptotic HMEC-1 death through activation of distinct signal transduction pathways. Remarkably, primary cultures of human microvascular endothelial cells, whose growth is inhibited by CXCL9, CXCL10, CXCL11, and CXCL4, expressed CXCR3-B, but not CXCR3-A. Finally, monoclonal antibodies raised to selectively recognize CXCR3-B reacted with endothelial cells from neoplastic tissues, providing evidence that CXCR3-B is also expressed in vivo and may account for the angiostatic effects of CXC chemokines. Evaluated by the FACULTY OF THOUSANDS. SCORE OF 4.8 MUST READ. PAPER CONTAINING A NEW FINDING AND A NOVEL INTERESTING HYPOTHESIS. IMPACT FACTOR 15.837
197
1537
1549
L.Lasagni; M.Francalanci; F.Annunziato; E.Lazzeri; S.Giannini; L.Cosmi; C.Sagrinati; B.Mazzinghi; C.Orlando; E.Maggi; F.Marra; S.Romagnani; M.Serio; P.Romagnani
File in questo prodotto:
File Dimensione Formato  
LASAGNI JEM-2003.pdf

Accesso chiuso

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: DRM non definito
Dimensione 732.88 kB
Formato Adobe PDF
732.88 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2158/311990
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 580
  • ???jsp.display-item.citation.isi??? ND
social impact